Abbott Laboratories (ABT) FCF Payout Ratio Growth (3y) (2012 - 2026)
Abbott Laboratories (ABT) FCF Payout Ratio Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -24.36% |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | -15.73% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 0.06% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 47.27% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -478.95% |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 0.49% |
| 10 | Zimmer Biomet Holdings | 19.21 Bn | 18.80 Bn | 1.54 Bn | -16.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -24.36% |
| Mar 31, 2026 | 0.91% |
| Dec 31, 2025 | -6.48% |
| Sep 30, 2025 | 8.01% |
| Jun 30, 2025 | 17.78% |
| Mar 31, 2025 | 32.10% |
| Dec 31, 2024 | 11.09% |
| Sep 30, 2024 | 7.70% |
| Jun 30, 2024 | 12.88% |
| Mar 31, 2024 | 62.28% |
| Dec 31, 2023 | 23.70% |
| Sep 30, 2023 | 18.32% |
| Jun 30, 2023 | 10.64% |
| Mar 31, 2023 | -13.42% |
| Dec 31, 2022 | 18.73% |
| Sep 30, 2022 | -0.98% |
| Jun 30, 2022 | -24.82% |
| Mar 31, 2022 | -31.72% |
| Dec 31, 2021 | -5.16% |
| Sep 30, 2021 | 9.81% |